REPORTS

Let’s Pullulate and Expand Your Business

Xarelto Market - Global Professional Analysis and Forecast to 2026

Oct 23, 2019  |  218 PAGES  |  REPORT CODE: CMM221839
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Xarelto market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 10.5% during the forecast period.

This report presents the market size and development trends by detailing the Xarelto market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Xarelto market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Xarelto industry and will help you to build a panoramic view of the industrial development.

Xarelto Market, By Type:

  • Type 1

  • Type 2

  • Type 3

Xarelto Market, By Application:

  • End-User 1

  • End-User 2

  • End-User 3

Some of the leading players are as follows:

  • Teva Pharmaceutical Industries Ltd. (Israel)

  • GlaxoSmithKline Plc. (UK)

  • Mitsubishi Tanabe Pharma Corporation (Japan)

  • Bayer Healthcare AG (Germany)

  • Eisai Inc. (US)

  • Abbott India Limited (India)

  • Bristol-Myers Squibb Company (US)

  • Pfizer, Inc. (US)

  • Boehringer Ingelheim (Germany)

  • Aspen Holdings (South Africa)

  • Sanofi S.A. (France)

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Xarelto Market: Technology Type Analysis

  • 4.1 Xarelto Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Xarelto Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Type 1

    • 4.3.2 Type 2

    • 4.3.3 Type 3

5 Xarelto Market: Product Analysis

  • 5.1 Xarelto Product Market Share Analysis, 2018 & 2026

  • 5.2 Xarelto Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Xarelto Market: Application Analysis

  • 6.1 Xarelto Application Market Share Analysis, 2018 & 2026

  • 6.2 Xarelto Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 End-User 1

    • 6.3.2 End-User 1

    • 6.3.3 End-User 3

7 Xarelto Market: Regional Analysis

  • 7.1 Xarelto Regional Market Share Analysis, 2018 & 2026

  • 7.2 Xarelto Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Teva Pharmaceutical Industries Ltd. (Israel)

    • 9.1.1 Teva Pharmaceutical Industries Ltd. (Israel) Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 GlaxoSmithKline Plc. (UK)

    • 9.2.1 GlaxoSmithKline Plc. (UK) Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Mitsubishi Tanabe Pharma Corporation (Japan)

    • 9.3.1 Mitsubishi Tanabe Pharma Corporation (Japan) Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Bayer Healthcare AG (Germany)

    • 9.4.1 Bayer Healthcare AG (Germany) Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Eisai Inc. (US)

    • 9.5.1 Eisai Inc. (US) Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Abbott India Limited (India)

    • 9.6.1 Abbott India Limited (India) Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Bristol-Myers Squibb Company (US)

    • 9.7.1 Bristol-Myers Squibb Company (US) Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Pfizer, Inc. (US)

    • 9.8.1 Pfizer, Inc. (US) Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Boehringer Ingelheim (Germany)

    • 9.9.1 Boehringer Ingelheim (Germany) Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Aspen Holdings (South Africa)

    • 9.10.1 Aspen Holdings (South Africa) Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Sanofi S.A. (France)

    • 9.11.1 Sanofi S.A. (France) Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

 

The List of Tables and Figures (Totals 65 Figures and 142 Tables)

  • Figure Type 1 Xarelto market, 2015 - 2026 (USD Million)

  • Figure Type 2 Xarelto market, 2015 - 2026 (USD Million)

  • Figure Type 3 Xarelto market, 2015 - 2026 (USD Million)

  • Figure End-User 1 market, 2015 - 2026 (USD Million)

  • Figure End-User 2 market, 2015 - 2026 (USD Million)

  • Figure End-User 3 market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Xarelto market, by country, 2015 - 2026 (USD Million)

  • Table North America Xarelto market, by type, 2015 - 2026 (USD Million)

  • Table North America Xarelto market, by product, 2015 - 2026 (USD Million)

  • Table North America Xarelto market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Xarelto market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Xarelto market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Xarelto market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Xarelto market, by type, 2015 - 2026 (USD Million)

  • Table Canada Xarelto market, by product, 2015 - 2026 (USD Million)

  • Table Canada Xarelto market, by application, 2015 - 2026 (USD Million)

  • Table Europe Xarelto market, by country, 2015 - 2026 (USD Million)

  • Table Europe Xarelto market, by type, 2015 - 2026 (USD Million)

  • Table Europe Xarelto market, by product, 2015 - 2026 (USD Million)

  • Table Europe Xarelto market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Xarelto market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Xarelto market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Xarelto market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Xarelto market, by type, 2015 - 2026 (USD Million)

  • Table Germany Xarelto market, by product, 2015 - 2026 (USD Million)

  • Table Germany Xarelto market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Xarelto market, by type, 2015 - 2026 (USD Million)

  • Table France Xarelto market, by product, 2015 - 2026 (USD Million)

  • Table France Xarelto market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Xarelto market, by type, 2015 - 2026 (USD Million)

  • Table Italy Xarelto market, by product, 2015 - 2026 (USD Million)

  • Table Italy Xarelto market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Xarelto market, by type, 2015 - 2026 (USD Million)

  • Table Spain Xarelto market, by product, 2015 - 2026 (USD Million)

  • Table Spain Xarelto market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Xarelto market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Xarelto market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Xarelto market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Xarelto market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Xarelto market, by type, 2015 - 2026 (USD Million)

  • Table China Xarelto market, by product, 2015 - 2026 (USD Million)

  • Table China Xarelto market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Xarelto market, by type, 2015 - 2026 (USD Million)

  • Table Japan Xarelto market, by product, 2015 - 2026 (USD Million)

  • Table Japan Xarelto market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Xarelto market, by type, 2015 - 2026 (USD Million)

  • Table India Xarelto market, by product, 2015 - 2026 (USD Million)

  • Table India Xarelto market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Xarelto market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Xarelto market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Xarelto market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Xarelto market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Xarelto market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Xarelto market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Xarelto market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Xarelto market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Xarelto market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Xarelto market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Xarelto market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Xarelto market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Xarelto market, by application, 2015 - 2026 (USD Million)

  • Table MEA Xarelto market, by country, 2015 - 2026 (USD Million)

  • Table MEA Xarelto market, by type, 2015 - 2026 (USD Million)

  • Table MEA Xarelto market, by product, 2015 - 2026 (USD Million)

  • Table MEA Xarelto market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Xarelto market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Xarelto market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Xarelto market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Xarelto market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Xarelto market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Xarelto market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Teva Pharmaceutical Industries Ltd. (Israel) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GlaxoSmithKline Plc. (UK) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mitsubishi Tanabe Pharma Corporation (Japan) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bayer Healthcare AG (Germany) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Eisai Inc. (US) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Abbott India Limited (India) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bristol-Myers Squibb Company (US) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer, Inc. (US) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Boehringer Ingelheim (Germany) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Aspen Holdings (South Africa) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi S.A. (France) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top